Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis

INTRODUCTION: Post-marketing surveillance (PMS) is an integral part of monitoring adverse events (AEs) following approval of new drugs. Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). An analysis of PMS reports was conducted to evaluate the safety of tof...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Rheumatol Ther
Main Authors: Cohen, Stanley, Curtis, Jeffrey R., DeMasi, Ryan, Chen, Yan, Fan, Haiyun, Soonasra, Arif, Fleischmann, Roy
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2018
Teme:
Brief Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935628/
https://ncbi.nlm.nih.gov/pubmed/29470834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0097-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki